Search

Search Results
Results 17101 - 17110 of 18776 for breast cancer
  • White Paper - 24 Oct 2025
    Understand the major design strategies in Fc engineering aimed at unlocking the antibody immune code.
  • Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Norditropin FlexPro intended for persons living in Australia.
  • Drug - 8 Oct 2025
    Consumer Medicine Information (CMI) about Finasteride Viatris 5 (film-coated tablet) intended for persons living in Australia.
  • News - 15 Sep 2025
    Researchers analysed mortality data from 185 countries and found that while global non-communicable disease (NCD) deaths before age 80 declined from 2010 to 2019, progress slowed compared to...
  • News - 31 Jul 2025
    Discover how lymphoid structures and germinal centers provide powerful prognostic insights into colorectal cancer.
  • Drug - 11 Jul 2025
    Consumer Medicine Information (CMI) about Varivax intended for persons living in Australia.
  • Drug - 2 Jul 2025
    Consumer Medicine Information (CMI) about Filosir intended for persons living in Australia.
  • News - 27 Jun 2025
    Human breast milk is uniquely adapted to meet an infant's nutritional needs. Surprisingly, we still know very little about how milk is even made in the breast.
  • Drug - 26 Jun 2025
    Consumer Medicine Information (CMI) about Gilenya intended for persons living in Australia.
  • Drug - 25 Jun 2025
    Consumer Medicine Information (CMI) about Nexium Hp7 intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.